Visdios is a specialist in key opinion leader management, development, implement process and also manage all kind of KOL solutions across your company. We engage with our valuable customers to get a real understanding of their business requirements.
http://visdios.com/kol-management-india/
All You Wanted to Know about KOL Management.
This is a special issue with a focus on Pharma KOL Management as an introduction to the KOL Management Workshop by Knowledge Media Venturz
Kol program management and marketing functional trans genomicsDemet G. Sag
KOL Identification,
Leader Choice for the Task,
KOL Network and Workshops
Organizing a KOL Program,
KOL Management,
KOL Reimbursement
Marketing and Business Development
KOL Relationship & Brand Building in Pharma MarketingAnjali Makhijani
Key Opinion Leaders (KOLs) in Pharmaceutical Context are the clinical experts who can play a critical role in influencing the opinion and clinical practice of their peers and also the healthcare organizations. Thus it is important to have KOL Management as a part of the Marketing strategy.
KOL Management is a continuous process that involves identifying the right experts who are interested and aligned with your brand/molecule, profiling their key strengths and segmenting them according to their positions, mindset and collaboration preferences etc.
Involving KOLs throughout the product lifecycle helps in instant feedback, building long-term relationships and customer loyalty in a long run.
Optimizing KOL Relationships Report SummaryBest Practices
Key Opinion Leaders (KOLs) play a critical role in educating the medical and scientific communities to build awareness about the latest medical therapies and novel mechanisms of action. KOL relationship management has thus emerged as a necessary and vital part of brand success. In an effort to examine how leading pharmaceutical companies approach KOL management, this research by Best Practices, LLC identifies the key elements of KOL management excellence, from structure and strategies to MSL roles and KOL activity assessment.
Aligning the Activities and Goals of Field Based Teams for
Strengthened Corporate Sustainability
• Examining the disconnect between field based medical and corporate initiatives
• Acquiring and synthesizing field insights to drive clinical and corporate decision-making
• Demonstrating value of the expensive MSL and Advisor roles to the company
The Medical Science Liaison role is growing and being utilized in a number of various ways by different companies. This presentation discussed how they are being utilized.
Understand how the new regulatory laws and guidelines going into affect in 2012 will have an impact on pharmaceutical companies and the relationship between Medical Science Liaisons and KOLs.
All You Wanted to Know about KOL Management.
This is a special issue with a focus on Pharma KOL Management as an introduction to the KOL Management Workshop by Knowledge Media Venturz
Kol program management and marketing functional trans genomicsDemet G. Sag
KOL Identification,
Leader Choice for the Task,
KOL Network and Workshops
Organizing a KOL Program,
KOL Management,
KOL Reimbursement
Marketing and Business Development
KOL Relationship & Brand Building in Pharma MarketingAnjali Makhijani
Key Opinion Leaders (KOLs) in Pharmaceutical Context are the clinical experts who can play a critical role in influencing the opinion and clinical practice of their peers and also the healthcare organizations. Thus it is important to have KOL Management as a part of the Marketing strategy.
KOL Management is a continuous process that involves identifying the right experts who are interested and aligned with your brand/molecule, profiling their key strengths and segmenting them according to their positions, mindset and collaboration preferences etc.
Involving KOLs throughout the product lifecycle helps in instant feedback, building long-term relationships and customer loyalty in a long run.
Optimizing KOL Relationships Report SummaryBest Practices
Key Opinion Leaders (KOLs) play a critical role in educating the medical and scientific communities to build awareness about the latest medical therapies and novel mechanisms of action. KOL relationship management has thus emerged as a necessary and vital part of brand success. In an effort to examine how leading pharmaceutical companies approach KOL management, this research by Best Practices, LLC identifies the key elements of KOL management excellence, from structure and strategies to MSL roles and KOL activity assessment.
Aligning the Activities and Goals of Field Based Teams for
Strengthened Corporate Sustainability
• Examining the disconnect between field based medical and corporate initiatives
• Acquiring and synthesizing field insights to drive clinical and corporate decision-making
• Demonstrating value of the expensive MSL and Advisor roles to the company
The Medical Science Liaison role is growing and being utilized in a number of various ways by different companies. This presentation discussed how they are being utilized.
Understand how the new regulatory laws and guidelines going into affect in 2012 will have an impact on pharmaceutical companies and the relationship between Medical Science Liaisons and KOLs.
10 essential questions for successful kol managementexecutiveinsight
Here we present 10 questions to ask yourself when planning your KOL management strategy. In questions one to five, we first ask who you should reach out to and what to aim for with a KOL management programme. In the following questions we will examine how you can optimise the working relationship in a way that benefits all parties involved.
Method, tools and recommendations to boost Medical Science Liaisons Competence and performance.
Presentation of best practices to manage key opinion leaders
KOL Relationship Management in Pharma & Devices - Workshop HighlightsAnup Soans
Inside this Issue:
1. Sales Managers: Avoiding Irrelevance in Joint Field Work by K. Hariram
How to ensure that joint field work adds real value to the MR’s daily routine
2. Social Network Analysis for KOL Discovery by Salil Kallianpur
Identifying KOLs through their influence on the social network they are a part of
3. The Art and Science of KOL Management by Dr. Viraj Suvarna
Deep-dive into the art and science of identifying, selecting and engaging KOLs
4. A CEO’s perspective on KOL Management by K. Hariram
Identifying KOLs based on long-term strategy, not short term goals
5. Special Feature: How to Train Your Reps by Prof. Vivek Hattangadi
Applying Cognitive Load Theory to make training effective for your medical reps
6. No Admission! by Rakesh Tiwari
Why Reps are increasingly finding it difficult to get a foothold in the Doctor’s clinic
7. Snippets from a Pharma Field Force Veteran by Anirudha Sengupta
A veteran shares his experiences and insights on pharma sales
8. Uncertainties in Pharmaceutical Distribution Channel with Reference to Availability of New Products
New Product Planning in the Pharmaceutical IndustryAnthony Russell
Lecture presented in the Competitive Intelligence and Pricing course as part of the University of Southern California Master of Science in Healthcare Decision Analysis program. Presented on June 14, 2020 at USC via Zoom. The lectures gives an overview of what new product planning is in the pharmaceutical industry, what tools are used during new product evaluations, and the key elements of a new product business case. The lecture includes a couple of case studies to be worked on by the class.
Description of the ELITE Program based on four pillers: 1. the prescriber insight - 2. the brand preference mix - 3. the the high impact interactions - 4. Job passion
Highlights From 7th Medical Science Liaison/MSL ConferenceExL Pharma
Current trends, issues and challenges facing MSL's in the pharmaceutical industry. Presented at the 7th MSL Best Practices conference, April, 2010. For further information, please visit www.exlpharma.com
Sales Force Effectiveness is Dead ... or is it?
Five opportunities for pharma to get ‘back to basics’ and immediately lift sales performance.
Blackdot are a full service benchmarking, consulting, training & advisory firm exclusively focused on lifting sales force effectiveness & efficiency. Blackdot exist to assist their clients to achieve more predictable, repeatable, and sustainable sales performance.
What makes them unique is their total fixation on the use of data-driven, evidence-based techniques to understand what does (and does not) drive sales performance.
By viewing the ‘sales engine’ holistically, as an ecosystem of component parts that work interdependently to impact sales results, Blackdot are able to identify the root cause of what’s inhibiting and enabling your current performance, including quantifying the payoff in actually getting it right.
Armed with this knowledge, Blackdot stand alongside their clients who engage them to define, implement and embed change programs that bridge the gap between ‘hoping’ and ‘knowing’ they’ll deliver top and bottom line performance improvement.
Description of the Brand Booster Program which includes three innovative marketing approaches: the Brand Preference Mix to increase market share - the Behavioral Prescriber Segmentation to increase the efficiency of field forces and the Individual Prescriber Plan to fine tune the marketing mix
Go through this presentation to know about:
1) What every Medical Representative needs to discover before making Doctor Calls?
2) What lays the foundation for healthy prescription growth?
SHARES.VN - MẠNG LƯỚI INFLUENCER MARKETING LỚN NHẤT TẠI VIỆT NAMThủy Nguyễn
Shares.vn là mạng lưới marketing đầu tiên và lớn nhất tại Việt Nam kết nối những người có sức ảnh hưởng trên cộng đồng mạng & những người nổi tiếng với nhà quảng cáo.
Bi quyet giup noi dung duoc 100000 sharekhoahocseo
Đối với những người làm tiếp thị số, tạo ra một nội dung có khả năng viral (lan tỏa) được xem là thành công quyết định. Một nội dung đạt tới 100.000 lượt xem đồng nghĩa với việc có 100.000 cơ hội tiềm năng cho thương hiệu của bạn. Tuy nhiên, làm sao để đạt được con số này? Nó có khả thi không? Tất nhiên là có. Bí quyết nằm ở việc bạn hiểu những cơ sở khoa học để tạo ra những nội dung có khả năng viral.
10 essential questions for successful kol managementexecutiveinsight
Here we present 10 questions to ask yourself when planning your KOL management strategy. In questions one to five, we first ask who you should reach out to and what to aim for with a KOL management programme. In the following questions we will examine how you can optimise the working relationship in a way that benefits all parties involved.
Method, tools and recommendations to boost Medical Science Liaisons Competence and performance.
Presentation of best practices to manage key opinion leaders
KOL Relationship Management in Pharma & Devices - Workshop HighlightsAnup Soans
Inside this Issue:
1. Sales Managers: Avoiding Irrelevance in Joint Field Work by K. Hariram
How to ensure that joint field work adds real value to the MR’s daily routine
2. Social Network Analysis for KOL Discovery by Salil Kallianpur
Identifying KOLs through their influence on the social network they are a part of
3. The Art and Science of KOL Management by Dr. Viraj Suvarna
Deep-dive into the art and science of identifying, selecting and engaging KOLs
4. A CEO’s perspective on KOL Management by K. Hariram
Identifying KOLs based on long-term strategy, not short term goals
5. Special Feature: How to Train Your Reps by Prof. Vivek Hattangadi
Applying Cognitive Load Theory to make training effective for your medical reps
6. No Admission! by Rakesh Tiwari
Why Reps are increasingly finding it difficult to get a foothold in the Doctor’s clinic
7. Snippets from a Pharma Field Force Veteran by Anirudha Sengupta
A veteran shares his experiences and insights on pharma sales
8. Uncertainties in Pharmaceutical Distribution Channel with Reference to Availability of New Products
New Product Planning in the Pharmaceutical IndustryAnthony Russell
Lecture presented in the Competitive Intelligence and Pricing course as part of the University of Southern California Master of Science in Healthcare Decision Analysis program. Presented on June 14, 2020 at USC via Zoom. The lectures gives an overview of what new product planning is in the pharmaceutical industry, what tools are used during new product evaluations, and the key elements of a new product business case. The lecture includes a couple of case studies to be worked on by the class.
Description of the ELITE Program based on four pillers: 1. the prescriber insight - 2. the brand preference mix - 3. the the high impact interactions - 4. Job passion
Highlights From 7th Medical Science Liaison/MSL ConferenceExL Pharma
Current trends, issues and challenges facing MSL's in the pharmaceutical industry. Presented at the 7th MSL Best Practices conference, April, 2010. For further information, please visit www.exlpharma.com
Sales Force Effectiveness is Dead ... or is it?
Five opportunities for pharma to get ‘back to basics’ and immediately lift sales performance.
Blackdot are a full service benchmarking, consulting, training & advisory firm exclusively focused on lifting sales force effectiveness & efficiency. Blackdot exist to assist their clients to achieve more predictable, repeatable, and sustainable sales performance.
What makes them unique is their total fixation on the use of data-driven, evidence-based techniques to understand what does (and does not) drive sales performance.
By viewing the ‘sales engine’ holistically, as an ecosystem of component parts that work interdependently to impact sales results, Blackdot are able to identify the root cause of what’s inhibiting and enabling your current performance, including quantifying the payoff in actually getting it right.
Armed with this knowledge, Blackdot stand alongside their clients who engage them to define, implement and embed change programs that bridge the gap between ‘hoping’ and ‘knowing’ they’ll deliver top and bottom line performance improvement.
Description of the Brand Booster Program which includes three innovative marketing approaches: the Brand Preference Mix to increase market share - the Behavioral Prescriber Segmentation to increase the efficiency of field forces and the Individual Prescriber Plan to fine tune the marketing mix
Go through this presentation to know about:
1) What every Medical Representative needs to discover before making Doctor Calls?
2) What lays the foundation for healthy prescription growth?
SHARES.VN - MẠNG LƯỚI INFLUENCER MARKETING LỚN NHẤT TẠI VIỆT NAMThủy Nguyễn
Shares.vn là mạng lưới marketing đầu tiên và lớn nhất tại Việt Nam kết nối những người có sức ảnh hưởng trên cộng đồng mạng & những người nổi tiếng với nhà quảng cáo.
Bi quyet giup noi dung duoc 100000 sharekhoahocseo
Đối với những người làm tiếp thị số, tạo ra một nội dung có khả năng viral (lan tỏa) được xem là thành công quyết định. Một nội dung đạt tới 100.000 lượt xem đồng nghĩa với việc có 100.000 cơ hội tiềm năng cho thương hiệu của bạn. Tuy nhiên, làm sao để đạt được con số này? Nó có khả thi không? Tất nhiên là có. Bí quyết nằm ở việc bạn hiểu những cơ sở khoa học để tạo ra những nội dung có khả năng viral.
Chia sẻ của ông NGUYỄN ĐÌNH THÀNH - Content Marketing - Digital Story 2014Digital Story
Slide tài liệu của diễn giả NGUYỄN ĐÌNH THÀNH - Giám đốc PR Chiến lược của Le Bros, trong buổi hội thảo mở màn CONTENT MARKETING - When click meets brick của chuỗi sự kiện DIGITAL STORY
Download bản đầy đủ tại đây: http://digitalstory.admicro.vn/vn/guest_speakers
Shares.vn - The leading influencer marketing platform in VietnamThủy Nguyễn
The first influencer marketing platform, www.shares.vn, provides services to help brands connect influencers at scale.
According to Scott Cook, the founder and CEO of Intuit, “A brand is no longer what we tell the consumer it is–it is what consumers tell each other it is.” He’s hit the nail on the head and the numbers show it. Influencers hold the power and it’ll be our job to cater to them.
Many pharmaceutical companies still prefer to deal with their stakeholders one-by-one in a controlled way. They are often at their most comfortable dealing with clinical opinion leaders, talking about the benefits of their products. But are they missing a trick?
Medical Affairs teams in Asia’s diverse markets need to collaborate with R&D and understand the science, the business and the regulations. They need to constantly think strategically and communicate effectively.
• How can Medical Affairs teams be even more impactful in enhancing your company’s scientific reputation?
• How can you better communicate the value of your products to KOLs and Healthcare professionals?
• What makes a successful Medical Affairs team in Asia?
Get the answers and more at the 3rd MEDICAL AFFAIRS FORUM ASIA {link} - the region’s longest running strategy forum where leading medical affairs professionals share best practices, discuss common issues and learn from industry experts to enhance scientific reputation and better communicate the value of products to KOLs.
http://www.pharmaconasia.com/medical-affairs-forum-asia
KOL compensation: Principles for success-Key principles and critical success factors to help improve your company’s thought leader
management function.
Find out how to tackle a shrinking thought leader (KOL) pool, elevated scrutiny and stringent spending caps to guarantee future success. Learn key findings from a benchmark study on European KOL fair market value compensation.
The best Medical Affairs organizations are evolving from a support-only function to a strategic partner of the business. Explore a common set of Medical Affairs challenges with other leaders from Pharma, Biotech, and Medical Device companies.
KOL Management Software can help Medical and Pharma companies in long run for adequate functioning of the business - Aissel Technologies, why wait Book a Free Demo to know more about our Software deals now...!
Medical Affairs Resources, Structures, and Trends (UPDATE) - Report SummaryBest Practices
The Update to the wildly popular Medical Affairs Resources, Structures, and Trends research from 2009 is ready! Contains linear data and new segmentation for emerging markets.
Charged with building and maintaining physician relationships, pharmaceutical Medical Affairs organizations typically oversee several important functions -- including publications, KOL programs, grants and medical education (CME) -- that have been impacted in recent years by a call for increased transparency. As such, forward-looking biopharmaceutical executives are beginning to evaluate Medical Affairs operations to ensure that the vital organization is appropriately structured and resourced to operate effectively in the current environment.
This Best Practices, LLC study explores how U.S. and global biopharmaceutical companies are structuring and managing their Medical Affairs organizations today. The study also examines recent trends in budget and staffing resources, key challenges and top success factors for the function.
The report is based on the insights of 68 Medical Affairs executives and managers at 50 leading global companies. The benchmark class in this study consists of a Mature Markets and Emerging Markets Segment. The Mature Market Segment includes 41 participants from pharma and 12 device respondents. The Emerging Markets Segment consists of 15 participants working in India, China, Brazil, and Turkey.
Effective pharmaceutical product management through health economics outcomes performance measurements.
Health Economics Outcomes Research - HEOR - has a widening role in accountable care and improved healthcare delivery results.
www.healthcaremedicalpharmaceuticaldirectory.com
John G. Baresky
https://www.linkedin.com/in/johngbaresky
#baresky
Running head HEALTH SERVICES IN RELATION TO ENVIRONMENTAL ANALY.docxcharisellington63520
Running head: HEALTH SERVICES IN RELATION TO ENVIRONMENTAL ANALYSIS 1
HEALTH SERVICES IN RELATION TO ENVRIRONMENTAL ANALYSIS 8
Health Services In Relation to Environmental Analysis
Dr. Mountasser Kadrie
July 27, 2014
As a manager in Ford Rehabilitation centre, I have encountered several challenges in both external environment and internal environment that have greatly challenged the increasing demands of my patients’ services as well as failure of the reimbursements of funds by the insurance providers. Environmental conditions normally affect human health in varied means. Interactions between the environment and human health usually lead to very complex ethical queries that are related to health policy decisions. There are various factors in the environment that can lead to risks and the same time benefits. They include genetically modified plants, nanotechnology, bio fuels and other technology. There is a body of evidence that have emerged saying that environment can affect the health of human being and at the same time human health can have impact to the environment.
The external factors are factors in the environment that cannot be controlled by an organization. There are several external factors that affect many health organizations; these factors include political conditions, government policies and regulations, technological environment and social environment. In my organization the two key external factors affecting my company are the social environment and technological environment. Social factors have developed challenge in the Ford rehabilitation centre. This is because many patient customers have varied and different types of beliefs which make the relations in the health centre challenged. It have become problematic to deal with some patients since it is difficult to know the type of services they need based on where they have come from. Various patients have diverse transformation in attitude towards health care. The patients are however very demanding in my organization because each one of them needs to be handled differently based on community variations. In order to curb this, as manager I have decided to implement several programs that will promote cooperation between my patients as well amendments that will bring in suitable services to each patient. Implementation of this programs will enable my organization to continue being indispensible and financially stable despite the social challenges affecting the availability of patients in the organization.
Another external factor in the environment that will have a great impact in my company is technological environment. Implementation of more advanced methods to serve my customers is likely to improve patients’ attendance and this will boost the compan.
Healthcare Reform & Physician Loyalty: What Can CRM Do To Support ACOs?Perficient, Inc.
Martin Sizemore, Enterprise Architect at Perficient, and Lisa Anderson, CRM Solution Architect at Perficient, discuss Consumerism in Healthcare, Physician Practice Challenges & Alignment, and provide a Physician Loyalty Campaign Demo
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Performance Standards for Antimicrobial Susceptibility Testing
Key Opinion Leader Management
1. Who is Key Opinion Leader?
Presented by
Visdios
Web: http://visdios.com/kol-management-india/
2. What is KOL?
• KOL is a term named as Key Opinion Leader.
• Key Opinion Leaders are important doctor,
physician and members of medical community
who’s opinion are highly appreciated and who
influences other doctors and physicians.
• The first responsibility of an life science organization is to
maintain peer-to-peer relationships with KOL’s.
http://visdios.com/kol-management-india/
3. • As pharmaceutical and life-sciences companies search for the
most effective, efficient ways to manage collaboration with
the physicians who conduct research, write articles, or speak
on their behalf, relationship management of the interaction
with these elite physicians, or key opinion leaders (KOLs), has
ultimately emerged as an individual business discipline.
• Similar to CRM, KOL management is an essential component
for marketers and medical staff throughout the life-cycle
process of a specific drug or product.
http://visdios.com/kol-management-india/
4.
5. • By sustaining a business process that creates and
maintains meaningful and collaborative relationships
between KOLs and business functions from marketing
to medical affairs, pharmaceutical and life-sciences
companies can experience increased share of voice and
accelerated adoptions at the global, national, and
regional levels.
• A CEO of a major pharmaceuticals company recently
told a group of analysts that effectively managing KOL
relationships was essential to companies' future
products and market expansion.
http://visdios.com/kol-management-india/
6. • As physicians strive to choose from a myriad of drug options
for their patients, they often turn to fellow key opinion
leading physicians for knowledge and advice on specific drugs.
• Key opinion leaders possess a unique credibility, as their
validity often stems from years of industry experience and
medical affiliations.
http://visdios.com/kol-management-india/
7. • As a result, pharmaceutical and life-sciences companies have
begun relying heavily on key opinion leaders to help establish
the knowledge base about their drugs and expand their
markets throughout all stages of life-cycle management.
• Like customers, KOLs are an extremely valuable and necessary
component of any company's success.
http://visdios.com/kol-management-india/
8. • As such, KOL relationship management and customer
relationship management possess similar business
philosophies in which both the customers and KOLs play a
central and critical role within all business activities.
• Both KOL management and CRM enable organizations to
better manage those important and often complex
relationships through systems, processes, and procedures.
http://visdios.com/kol-management-india/
9. • Essentially, the goal of both customer and KOL management
systems is to create and maintain lasting and mutually
beneficial relationships.
http://visdios.com/kol-management-india/